136 related articles for article (PubMed ID: 24415495)
1. Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience : Education and Barriers assessment for Jewish Genetic Diseases.
Warsch JR; Warsch S; Herman E; Zakarin L; Schneider A; Hoffman J; Wasserman D; Barbouth D
J Community Genet; 2014 Jul; 5(3):223-31. PubMed ID: 24415495
[TBL] [Abstract][Full Text] [Related]
2. Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program.
Hegwer G; Fairley C; Charrow J; Ormond KE
J Genet Couns; 2006 Feb; 15(1):61-70. PubMed ID: 16468087
[TBL] [Abstract][Full Text] [Related]
3. Practices in synagogues regarding Jewish genetic disease education.
Thomsen AJ; Matthews AL; Mitchell AL; Cohen L
J Genet Couns; 2020 Dec; 29(6):1041-1049. PubMed ID: 32091143
[TBL] [Abstract][Full Text] [Related]
4. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the model of offering expanded genetic carrier screening to high school students within the Sydney Jewish community.
Barlow-Stewart K; Bardsley K; Elan E; Fleming J; Berman Y; Fleischer R; Recsei K; Goldberg D; Tucker J; Burnett L
J Community Genet; 2022 Feb; 13(1):121-131. PubMed ID: 34846685
[TBL] [Abstract][Full Text] [Related]
6. Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.
Akler G; Birch AH; Schreiber-Agus N; Cai X; Cai G; Shi L; Yu C; Larmore AM; Mendiratta-Vij G; Elkhoury L; Dillon MW; Zhu J; Mclellan AS; Suer FE; Webb BD; Schadt EE; Kornreich R; Edelmann L
Mol Genet Genomic Med; 2020 Feb; 8(2):e1053. PubMed ID: 31880409
[TBL] [Abstract][Full Text] [Related]
7. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
Rozenberg R; Pereira Lda V
Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
[TBL] [Abstract][Full Text] [Related]
8. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
Kronn D; Jansen V; Ostrer H
Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
[TBL] [Abstract][Full Text] [Related]
9. Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.
Grinzaid KA; Page PZ; Denton JJ; Ginsberg J
J Genet Couns; 2015 Jun; 24(3):381-7. PubMed ID: 25502003
[TBL] [Abstract][Full Text] [Related]
10. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.
Schwartz MD; Benkendorf J; Lerman C; Isaacs C; Ryan-Robertson A; Johnson L
Cancer; 2001 Aug; 92(4):932-40. PubMed ID: 11550168
[TBL] [Abstract][Full Text] [Related]
11. Study of carrier frequency of Warsaw breakage syndrome in the Ashkenazi Jewish population and presentation of two cases.
Rabin R; Hirsch Y; Johansson MM; Ekstein J; Zeevi DA; Keena B; Zackai EH; Pappas J
Am J Med Genet A; 2019 Oct; 179(10):2144-2151. PubMed ID: 31287223
[TBL] [Abstract][Full Text] [Related]
12. A collaborative genetic carrier screening model for the British Ashkenazi Jewish community.
Ziff M; Harris J
J Community Genet; 2022 Feb; 13(1):133-135. PubMed ID: 34841494
[TBL] [Abstract][Full Text] [Related]
13. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
[TBL] [Abstract][Full Text] [Related]
14. Community attitudes towards a Jewish community BRCA1/2 testing program.
Cousens N; Kaur R; Meiser B; Andrews L
Fam Cancer; 2017 Jan; 16(1):17-28. PubMed ID: 27480161
[TBL] [Abstract][Full Text] [Related]
15. Changes in young women's awareness, attitudes, and perceived barriers to using emergency contraception.
Aiken AM; Gold MA; Parker AM
J Pediatr Adolesc Gynecol; 2005 Feb; 18(1):25-32. PubMed ID: 15749581
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Pharmacy and Therapeutic (P&T) Committee member knowledge, attitudes and ability regarding the use of comparative effectiveness research (CER) in health care decision-making.
Tang DH; Warholak TL; Hines LE; Hurwitz J; Brown M; Taylor AM; Brixner D; Malone DC
Res Social Adm Pharm; 2014; 10(5):768-80. PubMed ID: 24480384
[TBL] [Abstract][Full Text] [Related]
17. A study of older adults attending a program on human sexuality: a pilot study.
Brower HT; Tanner LA
Nurs Res; 1979; 28(1):36-9. PubMed ID: 252702
[TBL] [Abstract][Full Text] [Related]
18. Effects of an Education Intervention on Nursing Students' Knowledge and Attitudes Regarding Skin Self-Examination and Skin Cancer Risks.
Erkin Ö; Aygün Ö
J Nurs Res; 2020 Feb; 28(1):e62. PubMed ID: 31935204
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pan-ethnic and ethnic-based carrier screening panels for individuals of Ashkenazi Jewish descent.
Rosenblum LS; Zhu H; Zhou Z; Teicher J; Heim RA; Leach NT
J Genet Couns; 2020 Feb; 29(1):56-66. PubMed ID: 31663226
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.
Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB
Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
